Stay updated on Daratumumab in Waldenström Macroglobulinemia Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Waldenström macroglobulinemia is now listed as a condition on the page, and a Resources section has been added with a link to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T00:22:27.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added and v3.4.3 removed; this appears to be a backend/UI update with no visible changes to the study details.
    Difference
    0.1%
    Check dated 2026-03-18T17:45:36.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:18:45.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The lapse-in-funding notice and the earlier Revision: v3.4.1 entry were removed from the page.
    Difference
    0.4%
    Check dated 2026-02-11T04:49:25.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    A site-wide notice about a lapse in government funding stating that information may not be up to date has been added, and the page revision indicator updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:28:59.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Added a glossary toggle and standardized capitalization for several labels (Last Update Submitted that Met QC Criteria; No FEAR Act Data). The revision also updates the version to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T03:54:39.000Z thumbnail image

Stay in the know with updates to Daratumumab in Waldenström Macroglobulinemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Waldenström Macroglobulinemia Clinical Trial page.